Better Antibodies for Diagnostics
SDIX is a biotechnology company with a core expertise in creating better antigens, better antibodies and better assays for the diagnostics and pharmaceutical markets. For over 20 years, SDIX has been a leading immuno-solutions company, developing results-oriented and innovative antibody-based solutions that enable customers to meet high performance research, diagnostic and commercialization objectives.
Services for In Vitro Diagnostics (IVD)
- Antibody Development – monoclonal (mAb) and polyclonal (pAb)
- Assay Specific Antibodies – Custom Formulation
- Large Scale mAb (in vitro and in vivo) and pAb Manufacturing
SDIX offers various programs and technologies for antibody development. This includes innovative antibody development methods such as SDIX Genomic Antibodies®, conventional peptide, protein and recombinant protein-based methods.
SDIX Genomic Antibody Technology® (GAT) is an innovative technology for antibody development. The technology uses immunization with DNA fragments coding for intact protein domains. DNA immunization results in in vivo mammalian protein expression and post translational modification of highly pure protein antigens. The use of fragments representing intact protein domains provides for native protein folding and, importantly, site-directed antibody targeting. The end result is a highly specific and sensitive antibody that recognizes conformational epitopes on native proteins.
Discover more about our antibody development capabilities and why our reagents are considered to be one of best in the industry.
Besides providing our core services, we offer a comprehensive catalog of IVD antibodies which includes hs Troponin I, hs CRP, Strep A, Apo-A1, Apo-B, Micro Alb, AGP, CRP, IgM, C3, C4, HPT, IgM, IgA, IgG, Ceruloplasmin and many other plasma protein antibodies. View our complete list of IVD reagent products.